Latest Trial Indicates Anti-Malarial Drug Does Not Reduce COVID Mortality
The latest pharma research updates: Another hydroxychloroquine evaluation; AbbiVie extends its monopoly on pricey cancer drug; and research on radiation and COVID.
Archives: Morning Breakouts
19,581 - 19,600 of 112,763 Results
-
-
Critics Say New COVID Reporting System Could Overwhelm Hospitals, Lead To Drug Shortages
The Trump administration announced this week that hospitals should now report data about coronavirus patients, supplies and bed capacity directly to the Department of Health and Human Services, rather than the Centers for Disease Control and Prevention. In other health industry news, Georgia revised its request for changes to the insurance marketplace, and doctors and employers team up to offer a new health care payment model.
By khnlaureno -
A COVID Vaccine Progress Report
As researchers move quickly to develop a vaccine, other researchers raise questions about its delivery method and its safe use with pregnant women.
By khnlaureno -
Chinese Drug Firm Began Human Trials Of COVID Vaccine Before Approval
The government-owned drug maker tested its vaccine candidate on human volunteers, including some of its employees, in March. Official approval was given in April. The rush underscores the enormous stakes as China competes with U.S. and British companies for a successful vaccine. The company also announced it has begun Phase III trials on a vaccine.
By khnlaureno -
COVID Wreaks Havoc On Republicans
Republican politicians are finding that the COVID-19 epidemic is undermining support. Mitch McConnell responds with a coronavirus relief plan.
By khnlaureno -
And Democrats Respond
Former President Barack Obama criticizes the government response to the epidemic, while House Democrats push to probe federal government largess to companies with ties to the Trump administration.
By khnlaureno -
CMS Chief Seema Verma Mishandled Contracts, HHS Inspector General Says
Centers for Medicare and Medicaid Services administrator Seema Verma sharply disputed the findings. In a response, she said the agency has “deep concerns” with the conclusions, which “are based on unsubstantiated assumptions and incomplete analysis.”
By khnlaureno -
Deaths Of 2 Migrant Children Could Have Been Prevented, Doctors Testify
Both children, who were in the custody of Border Patrol agents at the U.S.-Mexico border, died in December 2018.
By khnlaureno -
Hopes Of Abating Opioid Epidemic Tempered By Overdose Deaths In 2019
After a dip in 2018, the number of Americans who died of opioid overdoses rose back up in 2019 to a record 71,000, according to CDC data. Preliminary numbers forecast that 2020 could be even worse.
By khnlaureno -
From 75 Hours To 8: CMS Loosened Nursing Home Aide Training Requirements During Pandemic
The nursing home industry previously lobbied the Trump administration to relax regulations to certify nurse aides. At the start of the pandemic, the Centers for Medicare and Medicaid Services began to allow caregivers to complete eight hours of online training, instead of the 75 previously required.
By khnlaureno -
Texas Prepares For Overflow Of Morgues As Daily Case Record Reported
Developments in the coronavirus pandemic are reported out of Texas, Nebraska, Arizona, Pennsylvania and Missouri.
By khnlaureno -
White House Backs Off From Fauci Criticism
President Donald Trump, Vice President Mike Pence and Senate Majority Leader Mitch McConnell all deliver a message of support for Dr. Anthony Fauci after a top Trump adviser criticized him in an op-ed. Meanwhile, Fauci comments on the "bizarre" tension in an interview with The Atlantic.
By khnlaureno -
COVID Cases Soar To New Highs As State Leaders Scramble To Respond
Over 36,000 positive tests for the coronavirus were confirmed Wednesday in just four states alone: Arizona, California, Florida and Texas.
By khnlaureno -
First Edition: July 16, 2020
Today's early morning highlights from the major news organizations.
By khnlaureno -
Different Takes: Channel More Funding To Community-Based Health Organizations; Time To Expand Aid-In-Dying To More Patients
Opinion pages focus on these health issues and others.
By janicelkff -
Viewpoints: The Price Of Lockdowns; Slow Testing Results In Hard-Hit Communities
Editorial writers weigh in on issues surrounding the pandemic -- testing, the economy, the schools and Anthony Fauci.
By janicelkff -
EU Approves Lynparza To Fight Type Of Pancreatic Cancer
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
By khnlaureno -
Perspectives: Despite The Rush, Remdesivir Needs A Large Clinical Trial
Recent commentaries about drug-cost issues.
By khnlaureno -
Drug Investments Under Fire Over Possible Conflicts Of Interest
HHS says a Trump aide can sidestep ethics disclosures while making decisions about government contracts; management consulting firm McKinsey scoops up COVID-related contracts; lawmakers skeptical of vaccine developers' "no-profit" pledge.
By khnlaureno -
Health Plans Can’t Deny Coverage For Treatments Broadly Geared To Disabled Customers, Judge Says
News about several big hospital companies and also an early look at what hospitals have been charging for COVID care.
By khnlaureno